The grant from non-profit, CobiCure, will help PolyVascular accelerate its non-surgical, minimally invasive heart valve toward human clinical readiness.
CobiCure Grant Accelerates the First of its Kind Non-Surgical Heart Valve for Young Children With Congenital Heart Disease, Filling a Long-Standing Gap in Pediatric MedTech kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.
PolyVascular Awarded $2 Million Small Business Innovation Research Grant to Bring the First Polymer-Based Heart Valve for Children to Clinical Trials
Ultimate goal is to help 1 million pediatric patients with congenital heart disease around the world with more dependable and affordable solution
May 13, 2021 PolyVascular, leading the effort to improve children s lives with a novel polymeric transcatheter valve (PTV) for children, announced that it was awarded a $2 million Small Business Innovation Research (SBIR) Phase II grant earlier this year to bring its polymeric stent-mounted valve (SMV) to clinical trials within the next two years in an effort to address pediatric congenital heart disease (CHD), which affects over 1 million patients around the world.
PolyVascular awarded $2 Million SBIR grant
The company is working to bring the first polymer-based heart valve for children to clinical trials.
PolyVascular, leading the effort to improve children s lives with a novel polymeric transcatheter valve (PTV) for children, announced today that it was awarded a $2 million Small Business Innovation Research (SBIR) Phase II grant earlier this year to bring its polymeric stent-mounted valve (SMV) to clinical trials within the next two years in an effort to address pediatric congenital heart disease (CHD), which affects over 1 million patients around the world.
As part of the next stage of growth for the company,